These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38842127)

  • 1. Genitourinary syndrome of menopause: Evaluation of symptoms, using a questionnaire, in a research setting, before and after treatment.
    Briggs P; Karavadra B; Wyatt J; Lane S; Hapangama DK
    Post Reprod Health; 2024 Jun; ():20533691241246366. PubMed ID: 38842127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving the identification of genitourinary syndrome of menopause through the utilization of the Day-to-Day Impact of Vaginal Aging questionnaire.
    Mastroianni J; Thompson JA; Shifren JL; Zuckerman AL; Pereira K
    Menopause; 2020 Nov; 27(11):1295-1301. PubMed ID: 33110046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of genitourinary syndrome of menopause on well-being, functioning, and quality of life in postmenopausal women.
    Moral E; Delgado JL; Carmona F; Caballero B; Guillán C; González PM; Suárez-Almarza J; Velasco-Ortega S; Nieto Magro C;
    Menopause; 2018 Dec; 25(12):1418-1423. PubMed ID: 29944636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of Vulvovaginal Atrophy and Genitourinary Syndrome of Menopause and Its Impact on the Quality of Life of Postmenopausal Women in Central India.
    Ulhe SC; Acharya N; Vats A; Singh A
    Cureus; 2024 Feb; 16(2):e54802. PubMed ID: 38529421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convergent-Divergent Validity and Correlates of the Day-to-Day Impact of Vaginal Aging Domain Scales in the MsFLASH Vaginal Health Trial.
    Hunter MM; Guthrie KA; Larson JC; Reed SD; Mitchell CM; Diem SJ; LaCroix AZ; Huang AJ
    J Sex Med; 2020 Jan; 17(1):117-125. PubMed ID: 31812686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the German Day-to-Day Impact of Vaginal Aging (DIVA) Questionnaire in Peri- and Postmenopausal Women.
    Gabes M; Stute P; Apfelbacher C
    Sex Med; 2021 Aug; 9(4):100382. PubMed ID: 34130226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device.
    Vicariotto F; Raichi M
    Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyspareunia Related to GSM: Association of Total Vaginal Thickness via Transabdominal Ultrasound.
    Balica AC; Cooper AM; McKevitt MK; Schertz K; Wald-Spielman D; Egan S; Bachmann GA
    J Sex Med; 2019 Dec; 16(12):2038-2042. PubMed ID: 31542351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety.
    Vicariotto F; DE Seta F; Faoro V; Raichi M
    Minerva Ginecol; 2017 Aug; 69(4):342-349. PubMed ID: 28608667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society.
    The NAMS 2020 GSM Position Statement Editorial Panel
    Menopause; 2020 Sep; 27(9):976-992. PubMed ID: 32852449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pelvic floor muscle training as a treatment for genitourinary syndrome of menopause: A single-arm feasibility study.
    Mercier J; Morin M; Zaki D; Reichetzer B; Lemieux MC; Khalifé S; Dumoulin C
    Maturitas; 2019 Jul; 125():57-62. PubMed ID: 31133219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study.
    Moral E; Delgado JL; Carmona F; Caballero B; Guillán C; González PM; Suárez-Almarza J; Velasco-Ortega S; Nieto C;
    Climacteric; 2018 Apr; 21(2):167-173. PubMed ID: 29411644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship Between Genitourinary Syndrome of Menopause and 3D High-Frequency Endovaginal Ultrasound Measurement of Vaginal Wall Thickness.
    Peker H; Gursoy A
    J Sex Med; 2021 Jul; 18(7):1230-1235. PubMed ID: 34193368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasonographic measurement of vaginal thickness: Relation to menopausal status and genitourinary syndrome of menopause.
    Türk S; Ertürk Coşkun AD; Vural F
    J Obstet Gynaecol Res; 2022 Nov; 48(11):2911-2917. PubMed ID: 35896166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-centered change in the day-to-day impact of postmenopausal vaginal symptoms: results from a multicenter randomized trial.
    Gibson CJ; Huang AJ; Larson JC; Mitchell C; Diem S; LaCroix A; Newton KM; Reed SD; Guthrie KA
    Am J Obstet Gynecol; 2020 Jul; 223(1):99.e1-99.e9. PubMed ID: 31954158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Double-Blind Randomized Sham-Controlled Trial to Evaluate the Efficacy of Fractional Carbon Dioxide Laser Therapy on Genitourinary Syndrome of Menopause.
    Cruff J; Khandwala S
    J Sex Med; 2021 Apr; 18(4):761-769. PubMed ID: 33757774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexual function and quality of life in women with idiopathic premature ovarian insufficiency.
    Gosset A; Claeys JM; Huyghe E; Tremollieres F
    J Sex Med; 2023 Apr; 20(5):626-632. PubMed ID: 36881744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'As long as I have a restroom somewhere […], I am fine': a qualitative study on the perspectives of peri- and postmenopausal women on the impact of the urinary component of the genitourinary syndrome of menopause (GSM).
    Gabes M; Kann G; von Sommoggy J; Stute P; Apfelbacher CJ
    BMC Womens Health; 2021 Nov; 21(1):391. PubMed ID: 34743728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Er:YAG vaginal laser for management of women with genitourinary syndrome of menopause (GSM).
    Lin KL; Chou SH; Loo ZX; Liu YY; Cheng JC; Long CY
    Lasers Med Sci; 2022 Jun; 37(4):2203-2208. PubMed ID: 34988731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.